These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13638410)

  • 21. Creatine and muscular dystrophy. Relationship of creatine-creatinine metabolism to diet and drugs.
    BOURDAKOS N; WOLF S
    Arch Neurol; 1962 Jun; 6():439-50. PubMed ID: 13871865
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of delta- and gamma-tocopherol on creatinuria in progressive muscular dystrophy.
    MILHORAT AT
    Fed Proc; 1948 Mar; 7(1 Pt):80. PubMed ID: 18938605
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the treatment of progressive muscle dystrophy with an anabolic steroid].
    Ernst K
    Z Arztl Fortbild (Jena); 1966 Apr; 60(7):389-90. PubMed ID: 5983564
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathological aminoaciduria in muscular dystrophy].
    Rubio Pérez P; Ramos F; Vivanco F
    Rev Clin Esp; 1972 Sep; 126(6):509-14. PubMed ID: 4658356
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical observations on the significance of increased creatine excretion].
    Bernhardt W
    Z Neurol; 1972 Dec; 203(3):245-54. PubMed ID: 4120709
    [No Abstract]   [Full Text] [Related]  

  • 26. Creatine metabolism in skeletal muscle. II. creatine kinetics in man.
    Fitch CD; Lucy DD; Bornhofen JH; Dalrymple GV
    Neurology; 1968 Jan; 18(1 Pt 1):32-42. PubMed ID: 5688792
    [No Abstract]   [Full Text] [Related]  

  • 27. [Urinary excretion of a substance of a nucleotide nature in patients with progressive muscular dystrophy].
    Abe E
    Iryo; 1968 Dec; 22(12):1379-85. PubMed ID: 5717704
    [No Abstract]   [Full Text] [Related]  

  • 28. Muscular dystrophy. IX. Body growth, muscle strength, and serum solutes during methyltestosterone-KCl therapy.
    VAN DIERMEN J; WRATNEY MJ; MATEER FM; DANOWSKI TS
    AMA J Dis Child; 1959 Apr; 97(4):439-44. PubMed ID: 13636699
    [No Abstract]   [Full Text] [Related]  

  • 29. Muscular dystrophy associated with paroxysmal myoglobinuria and excessive excretion of ketosteroids.
    ACHESON D; McALPINE D
    Lancet; 1953 Aug; 265(6782):372-5. PubMed ID: 13085785
    [No Abstract]   [Full Text] [Related]  

  • 30. [Aminoaciduria in patients with progressive muscular dystrophy].
    Yoshino Y; Mozai T
    Rinsho Shinkeigaku; 1972 Apr; 12(4):197-204. PubMed ID: 4674560
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diphosphopyridin nucleotide in the urine in progressive muscular dystrophy].
    Kondo F; Abe E; Ikeda M; Mue S
    Iryo; 1967 Jul; 21(7):827-34. PubMed ID: 4295720
    [No Abstract]   [Full Text] [Related]  

  • 32. Muscular dystrophy. X. Endocrine and electrolyte effects of methyltestosterone-KCI therapy.
    DANOWSKI TS; VAN DIERMEN J; HEINEMAN AC; MATEER FM
    AMA J Dis Child; 1959 May; 97(5, Part 1):555-60. PubMed ID: 13649085
    [No Abstract]   [Full Text] [Related]  

  • 33. Urinary kinins and histamine in urine of progressive muscular dystrophy.
    Nakahara M; Sakahashi H
    Sapporo Igaku Zasshi; 1966; 29(1):1-7. PubMed ID: 6006282
    [No Abstract]   [Full Text] [Related]  

  • 34. Nandrolone-phenpropionate in progressive muscular dystrophy.
    BROWN IA; JAMES EM
    Arch Pediatr (N Y); 1961 Nov; 78():421-31. PubMed ID: 13873658
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the behavior of creatine-phosphokinase activity in the serum of patients with progressive muscular dystrophy].
    CUTILLO S; COLETTA A; REA F; BERNI CANANI M
    Boll Soc Ital Biol Sper; 1963 Jul; 39():769-72. PubMed ID: 14024396
    [No Abstract]   [Full Text] [Related]  

  • 36. Aminoaciduria in progressive muscular dystrophy. A family study.
    Beckmann R; Ritter H
    Ger Med Mon; 1967 Feb; 12(2):76-80. PubMed ID: 6044995
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372
    [No Abstract]   [Full Text] [Related]  

  • 39. [A clinical trial of creatine monohydrate in muscular dystrophy patients].
    Matsumura T; Yokoe M; Nakamori M; Hattori N; Saito T; Nozaki S; Fujimura H; Shinno S
    Rinsho Shinkeigaku; 2004 Oct; 44(10):661-6. PubMed ID: 15568480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STUDIES ON THE TREATMENT OF MYOPATHIES WITH SPECIAL REFERENCE TO FROZEN BLOOD THERAPY TO PROGRESSIVE MUSCULAR DYSTROPHIES.
    KATSUKI S; KUROIWA Y; MIYAZAKI T
    Kyushu J Med Sci; 1963 Aug; 14():175-88. PubMed ID: 14061431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.